Beigene Ltd (6160.HK)
Company Info
Highlights
HK$231.14B
-HK$2.23
HK$4.18B
HK$3.54B
HK$85.00 - HK$178.00
HK$195.50
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in Beigene Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Beigene Ltd (6160.HK) returned 27.99% year-to-date (YTD) and 40.47% over the past 12 months.
6160.HK
27.99%
8.25%
13.96%
40.47%
9.18%
N/A
^GSPC (Benchmark)
-3.77%
3.72%
-5.60%
8.55%
14.11%
10.45%
Monthly Returns
The table below presents the monthly returns of 6160.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 25.62% | 20.97% | -0.30% | -4.93% | -11.14% | 27.99% | |||||||
| 2024 | -17.76% | 17.06% | -10.28% | -0.53% | -6.40% | -2.65% | 13.92% | 19.04% | 23.78% | -15.83% | 5.75% | -14.83% | -0.36% |
| 2023 | 14.23% | -12.92% | -3.07% | 16.69% | -11.79% | -19.37% | 21.04% | -2.15% | -15.41% | 5.30% | -1.24% | -1.61% | -17.96% |
| 2022 | -20.12% | -1.40% | -4.42% | -13.70% | -17.83% | 14.60% | 2.44% | 2.18% | -21.39% | 22.15% | 16.46% | 16.39% | -16.65% |
| 2021 | 21.08% | -0.32% | 6.17% | 3.88% | 7.46% | -5.97% | -13.02% | 0.38% | 19.85% | -1.45% | -4.41% | -22.67% | 2.55% |
| 2020 | -8.50% | 0.66% | -17.10% | 26.92% | 0.10% | 17.01% | 12.33% | 14.20% | 16.28% | 1.65% | -3.14% | -5.82% | 57.00% |
| 2019 | -8.62% | 8.91% | -7.77% | -2.07% | -3.70% | 3.09% | 8.53% | 5.83% | -12.88% | 11.05% | 44.12% | -16.81% | 18.91% |
| 2018 | -0.65% | -1.51% | -35.05% | 26.76% | -2.44% | -21.40% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 80, 6160.HK is among the top 20% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Beigene Ltd (6160.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Beigene Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Beigene Ltd was 73.31%, occurring on May 12, 2022. The portfolio has not yet recovered.
The current Beigene Ltd drawdown is 49.61%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -73.31% | Sep 20, 2021 | 156 | May 12, 2022 | — | — | — |
| -42.36% | Nov 26, 2019 | 87 | Apr 1, 2020 | 68 | Jul 14, 2020 | 155 |
| -40.5% | Aug 30, 2018 | 39 | Oct 26, 2018 | 250 | Nov 1, 2019 | 289 |
| -32.94% | Feb 17, 2021 | 109 | Jul 27, 2021 | 37 | Sep 16, 2021 | 146 |
| -30.37% | Oct 14, 2020 | 41 | Dec 10, 2020 | 23 | Jan 14, 2021 | 64 |
Volatility
Volatility Chart
The current Beigene Ltd volatility is 31.84%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Beigene Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Beigene Ltd, comparing actual results with analytics estimates. The company met analyst expectations for EPS in the past quarter.
Valuation
The Valuation section provides an overview of how Beigene Ltd is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 6160.HK relative to other companies in the Biotechnology industry. Currently, 6160.HK has a P/S ratio of 60.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 6160.HK in comparison with other companies in the Biotechnology industry. Currently, 6160.HK has a P/B value of 8.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |